je.st
news
Ebola vaccine seems safe in first-stage testing
2014-11-27 01:00:27| Biotech - Topix.net
This handout file photo taken Sept. 2, 2014, provided by National Institute of Allergy and Infectious Diseases shows a 39-year-old woman, the first participant enrolled in VRC 207, receiving a dose of the investigational NIAID/GSK Ebola vaccine at the National Institute of Health Clinical Center in Bethesda, Md.
Tags: safe
testing
vaccine
ebola
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||